Experience in International Cooperation on Organization of Anti-Epidemic Measures by Health Care Institutions under COVID-19 Pandemic in the Republic of Uzbekistan

The results of the joint work of a panel of experts from Rospotrebnadzor and healthcare professionals of the Republic of Uzbekistan on organizing activities to counter the spread of the SARS-CoV-2 virus are described in the paper.

The goal of the study was to determine the main driving forces of COVID-19 spread in the Republic of Uzbekistan and develop an action plan to reduce the incidence of coronavirus infection caused by the SARS-CoV-2 virus.

Materials and methods. The organization of work in 14 health care institutions in Tashkent and Samarkand, as well as in Tashkent and Samarkand Regions, was analyzed: in 7 laboratories, 6 hospitals and 1 polyclinic. The routes for the movement of personnel, the demarcation of green and red zones, the features of disinfection and the use of personal protective equipment were studied. Attention is drawn to the diagnosis of COVID-19, the use of therapy aimed at reducing the period of virus shedding, the criteria for lifting quarantine restrictions for patients.

Results and discussion. The main factors in the organization of work of institutions that contribute to the spread of COVID-19 among medical personnel and the population have been identifed: the lack of equipped gateways between the red and green zones with the accessibility of adequate disinfection, the wrong choice of personal protective equipment, monitoring of contact persons for 10 days, discharge from hospitals based on clinical improvement. The incorrect use of antiviral therapy, the lack of differentiated approaches to the selection of optimal regimens have been noted. Proposals are formulated for organizing the work of healthcare institutions, taking into account the requirements of biological safety. The introduction of targeted measures in addition to those previously adopted has led to a signifcant improvement in the epidemic situation: the total number of active cases in the Republic of Uzbekistan, despite the increase in testing volumes, decreased from 3,686 people on August 23 to 2335 on October 27. Towards December 20, 2020, 97 % of patients recovered completely. All diagnostic triage centers in the Republic of Uzbekistan are closed due to the absence of patients with COVID-19, most of the country’s medical institutions previously re-profled for patients with coronavirus infection have returned to the routine operations.

1. Kutyrev V.V., Popova A.Yu., Smolensky V.Yu., Ezhlova E.B., Demina Yu.V., Safronov V.A., Karnaukhov I.G., Ivanova A.V., Shcherbakova S.A. [Epidemiological peculiarities of new coronavirus infection (COVID-2019). Communication 2: Peculiarities of epidemic process development in conjunction with performed anti-epidemic measures around the world and in the Russian Federation]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2020; (2):6–12. DOI: 10.21055/0370-1069-2020-2-6-12.

2. Kutyrev V.V., Popova A.Yu., Smolensky V.Yu., Ezhlova E.B., Demina Yu.V., Safronov V.A., Karnaukhov I.G., Ivanova A.V., Shcherbakova S.A. [Epidemiological features of new coronavirus infection (COVID-19). Communication 1: Modes of Implementation of Preventive and Anti-Epidemic Measures]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2020; (1):6–13. DOI: 10.21055/0370-1069-2020-1-6-13.

3. Saidaliev S.S., Mirzabaev D.S., Madaminov M.M. [Lessons learned from fghting coronavirus disease in the Republic of Uzbekistan]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2020; (2):138–40. DOI: 10.21055/0370-1069-2020-2-138-140.

4. Li W., Zhang B., Lu J., Liu S., Chang Z., Peng C., Liu X., Zhang P., Ling Y., Tao K., Chen J. Characteristics of household transmission of COVID-19. Clin. Inf. Dis. 2020; 71(8):1943–6. DOI: 10.1093/cid/ciaa450.

5. Levy C., Basmaci R., Bensaid P., Bru C.B., Coinde E., Dessioux E., Fournial C., Gashignard J., Haas H., Hentgen V., Huet F., Lalande M., Martinot A., Pons C., Romain A.S., Ursulescu N., Le Sage F.V., Raymond J., Béchet S., Toubiana J., Cohen R. Changes in Reverse Transcription Polymerase Chain Reaction-positive Severe Acute Respiratory Syndrome Coronavirus 2 Rates in Adults and Children According to the Epidemic Stages. Pediatr. Infect. Dis. J. 2020; 39(11):e369–72. DOI: 10.1097/INF.0000000000002861.

6. Gudbjartsson D.F., Helgason A., Jonsson H., Magnusson O.T., Melsted P., Norddahl G.L., Saemundsdottir J., Sigurdsson A., Sulem P., Agustsdottir A.B., Eiriksdottir B., Fridriksdottir R., Gardarsdottir E.E., Georgsson G., Gretarsdottir O.S., Gudmundsson K.R., Gunnarsdottir T.R., Gylfason A., Holm H., Jensson B.O., Jonasdottir A., Jonsson F., Josefsdottir K.S., Kristjansson T., Magnusdottir D.N., le Roux L., Sigmundsdottir G., Sveinbjornsson G., Sveinsdottir K.E., Sveinsdottir M., Thorarensen E.A., Thorbjornsson B., Löve A., Masson G., Jonsdottir I., Möller A.D., Gudnason T., Kristinsson K.G., Thorsteinsdottir U., Stefansson K. Spread of SARS-CoV-2 in the Icelandic Population. N. Engl. J. Med. 2020; 382(24):2302–15. DOI: 10.1056/NEJMoa2006100.

7. Contact tracing in the context of COVID-19. (Cited 01 Mar 2021). [Internet]. Available from: https://www.who.int/publications/i/item/contact-tracing-in-the-context-of-covid-19.

8. Macartney K., Quinn H.E., Pillsbury A.J., Koirala A., Deng L., Winkler N., Katelaris A.L., O’Sullivan M.V.N., Dalton C., Wood N.; NSW COVID-19 Schools Study Team. Transmission of SARSCoV-2 in Australian educational settings: a prospective cohort study. Lancet Child Adolesc. Health. 2020; 4(11):807–16. DOI: 10.1016/S2352-4642(20)30251-0.

9. [Interim guidelines for the prevention, diagnosis and treatment of novel coronavirus infection (COVID-19)]. Version 7 (06/03/2020). (Cited 25 Sept 2020). [Internet]. Available from: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_ %D0 %9CR_COVID-19_v7.pdf.

10. Ruzhentsova T.A., Chukhlyaev P.V., Khavkina D.A., Garbuzov A.A., Ploskireva A.A., Oseshnyuk R.A., Soluyanova T.N., Shestakova I.V., Vafn A.Yu., Dmitrikova E.P., Mustafaev D.M., Domostroeva T.N., Otpushchennikova M.V., Pokrovsky K.A., Rusanova M.G., Bystritsky D.A., Markova T.N., Kaplun E.A., Petina D.V., Kostina N.E., Lesina V.S., Shcherbak S.G., Agaf’ina A.S., Bruk Yu.F., Bronov O.Yu., Shultz E.I., Krasavina E.N., Samsonov M.Yu., Zinchenko A.V., Nikol’skaya M.V., Razzhivina V.A., Filon O.V. [Efcacy and safety of favipiravir in a complex therapy of mild to moderate COVID-19]. Infektsionnye Bolezni: Novosti, Mneniya, Obuchenie [Infectious Diseases: News, Opinions, Training]. 2020; 4(9):26–38. DOI: 10.33029/2305-3496-2020-9-00-0.

11. Emergency Dashboard WHO (COVID-19). (Cited 25 Sept 2020). [Internet]. Available from: https://covid19.who.int/region/euro/country/uz.